$BXRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Baudax Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Baudax Bio, Inc.. Get notifications about new insider transactions in Baudax Bio, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | BXRX | Baudax Bio, Inc. | Baskies Arnold M | Director | Buy | P | 0.82 | 10,000 | 8,200 | 86,452 | 76.5 K to 86.5 K (+13.08 %) |
| May 10 2021 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Buy | P | 0.83 | 6,000 | 4,992 | 356,307 | 350.3 K to 356.3 K (+1.71 %) |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Baskies Arnold M | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Baskies Arnold M | Director | Grant | A | 0.00 | 56,452 | 0 | 76,452 | 20 K to 76.5 K (+282.26 %) |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 56,452 | 0 | 119,985 | 63.5 K to 120 K (+88.85 %) |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Grant | A | 0.00 | 56,452 | 0 | 76,452 | 20 K to 76.5 K (+282.26 %) |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 56,452 | 0 | 132,185 | 75.7 K to 132.2 K (+74.54 %) |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Grant | A | 0.00 | 56,452 | 0 | 107,185 | 50.7 K to 107.2 K (+111.27 %) |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
| Apr 08 2021 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Grant | A | 0.00 | 56,452 | 0 | 117,785 | 61.3 K to 117.8 K (+92.04 %) |
| Mar 16 2021 | BXRX | Baudax Bio, Inc. | Casten Richard S | Chief Financial Off ... | Buy | P | 1.41 | 25,000 | 35,180 | 125,000 | 100 K to 125 K (+25.00 %) |
| Mar 10 2021 | BXRX | Baudax Bio, Inc. | Casten Richard S | Chief Financial Off ... | Option Exercise | A | 1.21 | 255,000 | 308,550 | 255,000 | |
| Mar 10 2021 | BXRX | Baudax Bio, Inc. | Casten Richard S | Chief Financial Off ... | Option Exercise | A | 1.21 | 15,000 | 18,150 | 15,000 | |
| Mar 10 2021 | BXRX | Baudax Bio, Inc. | Casten Richard S | Chief Financial Off ... | Grant | A | 0.00 | 85,000 | 0 | 100,000 | 15 K to 100 K (+566.67 %) |
| Mar 10 2021 | BXRX | Baudax Bio, Inc. | Casten Richard S | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 1.30 | 60,000 | 78,000 | 60,000 | |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 1.30 | 23,077 | 30,000 | 23,077 | |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 1.30 | 26,658 | 34,655 | 69,251 | 95.9 K to 69.3 K (-27.80 %) |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 95,909 | 75.9 K to 95.9 K (+26.35 %) |
| Jan 20 2021 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 75,909 | 70.9 K to 75.9 K (+7.05 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 1.14 | 4,845 | 5,523 | 70,909 | 75.8 K to 70.9 K (-6.40 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 1.14 | 15,064 | 17,173 | 75,754 | 90.8 K to 75.8 K (-16.59 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 1.14 | 71,283 | 81,263 | 284,872 | 356.2 K to 284.9 K (-20.01 %) |
| Dec 09 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 1.14 | 11,732 | 13,374 | 356,155 | 367.9 K to 356.2 K (-3.19 %) |
| Aug 21 2020 | BXRX | Baudax Bio, Inc. | Baskies Arnold M | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Aug 21 2020 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| May 08 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Option Exercise | A | 3.05 | 34,574 | 105,451 | 34,574 | |
| May 08 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 22,951 | 0 | 63,533 | 40.6 K to 63.5 K (+56.55 %) |
| May 08 2020 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 3.05 | 34,574 | 105,451 | 34,574 | |
| May 08 2020 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 22,951 | 0 | 75,733 | 52.8 K to 75.7 K (+43.48 %) |
| May 08 2020 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Option Exercise | A | 3.05 | 34,574 | 105,451 | 34,574 | |
| May 08 2020 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Grant | A | 0.00 | 22,951 | 0 | 50,733 | 27.8 K to 50.7 K (+82.61 %) |
| May 08 2020 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Option Exercise | A | 3.05 | 34,574 | 105,451 | 34,574 | |
| May 08 2020 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Grant | A | 0.00 | 22,951 | 0 | 56,333 | 33.4 K to 56.3 K (+68.75 %) |
| Mar 30 2020 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Buy | P | 2.28 | 6,500 | 14,820 | 6,500 | 0 to 6.5 K |
| Mar 30 2020 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Buy | P | 2.44 | 25,000 | 61,000 | 52,782 | 27.8 K to 52.8 K (+89.99 %) |
| Mar 27 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Buy | P | 2.29 | 10,000 | 22,900 | 40,582 | 30.6 K to 40.6 K (+32.70 %) |
| Mar 27 2020 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Buy | P | 2.34 | 5,000 | 11,700 | 33,382 | 28.4 K to 33.4 K (+17.62 %) |
| Mar 27 2020 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Buy | P | 2.29 | 10,000 | 22,900 | 40,582 | 30.6 K to 40.6 K (+32.70 %) |
| Mar 27 2020 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Buy | P | 2.34 | 5,000 | 11,700 | 33,382 | 28.4 K to 33.4 K (+17.62 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Payment of Exercise | F | 8.51 | 1,725 | 14,680 | 90,818 | 92.5 K to 90.8 K (-1.86 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Buy | M | 0.00 | 6,000 | 0 | 92,543 | 86.5 K to 92.5 K (+6.93 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Payment of Exercise | F | 8.51 | 5,051 | 42,984 | 367,887 | 372.9 K to 367.9 K (-1.35 %) |
| Jan 29 2020 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Buy | M | 0.00 | 19,070 | 0 | 372,938 | 353.9 K to 372.9 K (+5.39 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 20,000 | 0 | 30,582 | 10.6 K to 30.6 K (+189.00 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 20,000 | 0 | 27,782 | 7.8 K to 27.8 K (+257.00 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Ashton William | Director | Grant | A | 0.00 | 20,000 | 0 | 27,782 | 7.8 K to 27.8 K (+257.00 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Option Exercise | A | 6.33 | 66,327 | 419,850 | 66,327 | |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 46,429 | 0 | 86,543 | 40.1 K to 86.5 K (+115.74 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | Lake Ryan David | Chief Financial Off ... | Grant | A | 0.00 | 36,096 | 0 | 40,114 | 4 K to 40.1 K (+898.36 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Option Exercise | A | 6.33 | 183,673 | 1,162,650 | 183,673 | |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Grant | A | 0.00 | 128,571 | 0 | 353,868 | 225.3 K to 353.9 K (+57.07 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | HENWOOD GERALDINE | President and CEO | Grant | A | 0.00 | 195,387 | 0 | 225,297 | 29.9 K to 225.3 K (+653.25 %) |
| Dec 09 2019 | BXRX | Baudax Bio, Inc. | ALTOMARI ALFRED | Director | Grant | A | 0.00 | 20,000 | 0 | 28,382 | 8.4 K to 28.4 K (+238.61 %) |
| Nov 22 2019 | BXRX | Baudax Bio, Inc. | Recro Pharma, Inc. | 10% Owner | Sell | J | 0.00 | 9,211,245 | 0 | 0 | 9.2 M to 0 (-100.00 %) |
| Nov 22 2019 | BXRX | Baudax Bio, Inc. | Recro Pharma, Inc. | 10% Owner | Buy | J | 0.00 | 9,211,145 | 0 | 9,211,245 | 100 to 9.2 M (+9,211,145.00 %) |
Page: 1